HEPATITIS B NANOPARTICLE-BASED VACCINE FOR INFLUENZA VIRUS Read more about HEPATITIS B NANOPARTICLE-BASED VACCINE FOR INFLUENZA VIRUS India202017008138Filed on 2018-08-02
HEPATITIS B NANOPARTICLE-BASED VACCINE FOR INFLUENZA VIRUS Read more about HEPATITIS B NANOPARTICLE-BASED VACCINE FOR INFLUENZA VIRUS European Patent18756111.3Filed on 2018-08-02
HEPATITIS B NANOPARTICLE-BASED VACCINE FOR INFLUENZA VIRUS Read more about HEPATITIS B NANOPARTICLE-BASED VACCINE FOR INFLUENZA VIRUS China201880063622.5Filed on 2018-08-02
Development of Mutations Useful for Attenuating Dengue Viruses and Chimeric Dengue Viruses Read more about Development of Mutations Useful for Attenuating Dengue Viruses and Chimeric Dengue Viruses Australia2020200863Filed on 2020-02-06
BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION Read more about BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION United Kingdom15708889.9Filed on 2015-02-27
BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION Read more about BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION France15708889.9Filed on 2015-02-27
BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION Read more about BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION Germany15708889.9Filed on 2015-02-27
BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION Read more about BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION Switzerland15708889.9Filed on 2015-02-27
BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION Read more about BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION Belgium15708889.9Filed on 2015-02-27
Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof Read more about Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof Singapore10201912944QFiled on 2017-09-01